Celgene, Bristol-Myers Squibb, Teva Pharmaceuticals USA and other drugmakers were hit with an antitrust lawsuit on Oct. 6 in California Northern District Court. The lawsuit was brought by BRS LLP on behalf of Mayo Clinic and Lifepoint Corporate Services, which allege that the defendants have conspired to delay generic competition in the market for Revlimid, compelling the plaintiffs to pay maximum prices for the chemotherapy drug. Counsel have not yet appeared for the defendants. The case is 3:23-cv-05144, Mayo Clinic v. Celgene Corporation.
This suit was surfaced by Law.com Radar, a cutting edge solution for new suit alerts from federal and state courts. Law.com Radar delivers AI-enhanced case summaries and daily case reports from more than 1,100 courts—all backed by the industry’s most trusted source for legal news and data. Click here to get started and be first to act on opportunities in your region, practice area or client sector.
